HomeTCRT • NASDAQ
Alaunos Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.00K | 100.00% |
Operating expense | 1.09M | -32.34% |
Net income | -1.07M | 36.21% |
Net profit margin | -53.65K | 68.10% |
Earnings per share | — | — |
EBITDA | -1.09M | 37.27% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 319.00K | -92.30% |
Total assets | 2.12M | -64.88% |
Total liabilities | 1.06M | -14.35% |
Total equity | 1.06M | — |
Shares outstanding | 1.64M | — |
Price to book | 4.23 | — |
Return on assets | -112.00% | — |
Return on capital | -174.94% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.07M | 36.21% |
Cash from operations | -772.00K | 59.73% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -772.00K | 59.73% |
Free cash flow | 603.50K | 145.59% |
Previous close
$2.79
Day range
$2.69 - $2.79
Year range
$1.31 - $11.00
Market cap
4.41M USD
Avg Volume
20.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1998
Website
Employees
1
